01547nam a2200193Ia 4500 MX-MdCICY 20260521091319.0 CICY B-12493 Production of Antibodies in Plants: Approaches and Perspectives Current Topics in MicroBiology and Immunology, 332, p.55-78, 2009 Advances in molecular biology, immunology, and plant biotechnology have changed the paradigm of plant as a food source to so-called plant bioreactor to produce valuable recombinant proteins. These include therapeutic or diagnostic monoclonal antibodies, vaccines, and other biopharmaceutical proteins. The plant as a bioreactor for the production of therapeutic proteins has several advantages, which include the lack of animal pathogenic contaminants, low cost of production, and ease of agricultural scale-up compared to other currently available systems. Thus, plants are considered to be a potential alternative to compete with other systems such as bacteria, yeast, or insect and mammalian cell culture. Plant production systems, particularly therapeutic antibodies, are very attractive to pharmaceutical companies to produce the antibodies in demand. Currently, we have successfully Ko, K. Brodzik, R. Steplewski, Z. https://drive.google.com/file/d/1S0gd90vwftGeLQwZy_Qlmq_5f0TFhA4x/view?usp=drivesdk Para ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx Loc REF1 250602s9999 xx |||||s2 |||| ||und|d 22639 22639 0 0 Loc 0 0 F1 CICY CICY RE 2025-06-25 0 B-12493 2025-06-25 15:38:55 2025-06-25 REF1